Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,848
Total Claims
$2.6M
Drug Cost
490
Beneficiaries
$5,396
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+282%
Cost per patient vs peers
$5,396 vs $1,411 avg
+55%
Brand preference vs peers
16.5% vs 10.6% avg
Brand vs Generic
Brand: 4,192 claims · $2.1M
Generic: 21,252 claims · $545K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 1,751 | $742K |
| Tenofovir Alafenamide | 145 | $218K |
| Sitagliptin Phos/Metformin Hcl | 340 | $213K |
| Empagliflozin | 251 | $172K |
| Dapagliflozin Propanediol | 134 | $88K |
| Diclofenac Epolamine | 191 | $83K |
| Sitagliptin Phosphate | 107 | $81K |
| Linagliptin | 106 | $71K |
| Icosapent Ethyl | 162 | $48K |
| Lactulose | 22 | $48K |
| Diclofenac Sodium | 573 | $47K |
| Linagliptin/Metformin Hcl | 52 | $33K |
| Metformin Hcl | 21 | $32K |
| Budesonide/Formoterol Fumarate | 71 | $31K |
| Omega-3 Acid Ethyl Esters | 320 | $30K |
Prescribing Profile
Patient Profile
70
Avg Age
49%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data